Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (631-640 of 666) with videos related to

Pageof 67
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature reviewKatharina Brück, Kitty J Jager, Evangelia Dounousi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2019
Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and FracturesJie Zheng, Winfried Maerz, Ingrid Gergei, et al.
Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 25, 2011
The German Chronic Kidney Disease (GCKD) study: design and methodsKai-Uwe Eckardt, Barbara Bärthlein, Seema Baid-Agrawal, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2024
Interactive exploration of adverse events and multimorbidity in CKDInga Steinbrenner, Fruzsina Kotsis, Robin Kosch, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKDKaitlin J Mayne, Natalie Staplin, David F Keane, et al.
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.
JAMA|November 7, 2025
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-AnalysisNatalie Staplin, Alistair J Roddick, Brendon L Neuen, et al.
The Lancet. Diabetes & Endocrinology|July 11, 2024
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trialsEllen M Apperloo, Brendon L Neuen, Robert A Fletcher, et al.
Pageof 67

Showing results (631-640 of 666) with videos related to

Sort By:
Pageof 67
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature reviewKatharina Brück, Kitty J Jager, Evangelia Dounousi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2019
Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and FracturesJie Zheng, Winfried Maerz, Ingrid Gergei, et al.
Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 25, 2011
The German Chronic Kidney Disease (GCKD) study: design and methodsKai-Uwe Eckardt, Barbara Bärthlein, Seema Baid-Agrawal, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2024
Interactive exploration of adverse events and multimorbidity in CKDInga Steinbrenner, Fruzsina Kotsis, Robin Kosch, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKDKaitlin J Mayne, Natalie Staplin, David F Keane, et al.
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.
JAMA|November 7, 2025
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-AnalysisNatalie Staplin, Alistair J Roddick, Brendon L Neuen, et al.
The Lancet. Diabetes & Endocrinology|July 11, 2024
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trialsEllen M Apperloo, Brendon L Neuen, Robert A Fletcher, et al.
Pageof 67